(To be published Q2 2025)

GLP-1: The Game Changer for the Food Industry?

GLP-1 medications are revolutionising diabetes management and weight loss, creating significant opportunities for the agri-food industry, particularly regarding protein consumption.

Why This Study is Crucial

Trending Topic: The rapid rise in the use of GLP-1 drugs makes this study particularly timely. It presents expert insights that provide an in-depth understanding of this new trend and shows how GLP-1 influences consumer behaviour.

New Market Opportunities for protein and dairy products tailored specifically to the needs of GLP-1 users.

Competitive Edge: This study will provide actionable insights and strategic recommendations on this emerging trend and its influence on consumer behaviour, so you can strategically position your business in this market.

What will you receive in the ‘GLP-1: the Game Changer for the Food Industry’ report?

✅ Overview of GLP-1 hormone functions: the role of GLP-1 in the body, its initial applications in diabetes management and its subsequent adaptation for weight loss.

✅ Overview of current GLP-1 drugs: comprehensive analysis of existing GLP-1 drugs, detailing their origins, manufacturers, dosage, administration methods, and regulatory approvals worldwide.

✅ US market analysis: estimate the current demand for GLP-1 treatments and forecast future trends in the US. Figures suggest that 8% of the United States population has already consumed GLP-1!

✅ Impact on retail and foodservice sales: present initial observations of the impact of GLP-1 treatments on retail and foodservice sales in the US, along with specific analysis of the development of “GLP-1 Companion Products”, identifying existing brands and product types already in the US market.

✅ Protein supplementation needs: estimate the necessary protein supplementation requirements, provide insights into the most used protein types and forecast future needs.

✅ GLP-1 companion products and supplements: identify existing brands and product categories already available in the US market.

✅ Conclusion: Assessment of the trend’s longevity, future drug generations, and possible impacts in other potential markets where GLP-1 drugs are, or would be, approved and have the same success as in the US.

This study isn’t just about understanding how GLP-1 treatments are shaping the agri-food industry…it’s about empowering your company so you can position your business at the forefront of emerging market opportunities.

Contact us today to discuss how this study can enhance your business.

For more information, click the proposal title or the download button above. If you have any questions, feel free to contact Mylène Potier.

What our clients say about our reports and expertise…

“…while many statistics can be found or bought elsewhere, talking behind the scenes with Gira’s accomplished experts adds the extra edge to market understanding”.

“The expert team at Gira is very skilled at cutting through the very complex and noisy environment within which the food industry operates and coming up with very clear insights and forecasts to help understand what is happening in the food industry”.

“Gira cuts through the masses in information and highlights what is important and relevant to our industry and how we are positioned against competing proteins”.

Check out our other expert market studies on our Reports Page.

To stay informed about this study and other exciting projects at Gira, follow us on our Gira LinkedIn page.